Bio-Techne (TECH) Cost of Revenue (2009 - 2026)

Bio-Techne's Cost of Revenue history runs 18 years deep, the most recent figure standing at $103.1 million for Q1 2026.

• In Q1 2026, Cost of Revenue rose 1.48% year-over-year to $103.1 million; the TTM figure through Mar 2026 stood at $424.3 million (up 2.5% YoY), while the FY2025 annual figure was $429.4 million, up 10.28% from the prior year.
• Cost of Revenue for Q1 2026 stood at $103.1 million, down from $104.6 million in the prior quarter.
• The five-year high for Cost of Revenue was $118.2 million in Q2 2025, with the low at $87.9 million in Q2 2022.
• The 5-year median for Cost of Revenue is $98.4 million (2025), against an average of $98.2 million.
• The sharpest annual moves came in 2022 and 2025: Cost of Revenue increased 18.12% in 2022, then dropped 7.51% in 2025.
• Bio-Techne's Cost of Revenue stood at $88.2 million in 2022, then increased by 8.83% to $96.0 million in 2023, then climbed by 7.43% to $103.1 million in 2024, then increased by 1.41% to $104.6 million in 2025, then decreased by 1.41% to $103.1 million in 2026.
• Business Quant data shows TECH's Cost of Revenue at $103.1 million in Q1 2026, $104.6 million in Q4 2025, and $98.4 million in Q3 2025.